Skip to main content
. 2024 Mar 25;14(3):e200276. doi: 10.1212/CPJ.0000000000200276

Figure 2. Cycles of Efgartigimod.

Figure 2

Time courses of efgartigimod in 34 patients with generalized MG. Numbers = the numbers of cycles of efgartigimod treatment. AChR+ = anti–acetylcholine receptor–positive; MuSK+ = anti–muscle-specific receptor tyrosine kinase-positive; C = COVID-19; e = eculizumab; g = intravenous immunoglobulin; m = intravenous high-dose methylprednisolone; N = nonresponder; R = responder.